Germany, Italy and South Korea respectively were numbers 2, 3 and 4 in this ranking.
How does New Zealand perform in Cardiovascular Drug?
Forecast: Diuretic Medicine Sales in New Zealand
- Million US Dollars PPP
- 2024 to 2028
- ReportLinker Research
Forecast: Cardiac Glycosides Sales in New Zealand
- Million US Dollars
- 2024 to 2028
- ReportLinker Research
Forecast: Diuretic Medicine Sales in New Zealand
- Million US Dollars
- 2024 to 2028
- ReportLinker Research
Forecast: Antiarrhythmic Medicine Sales in New Zealand
- Million US Dollars PPP
- 2024 to 2028
- ReportLinker Research
Forecast: Antihypertensive Medicine Sales in New Zealand
- Million New Zealand Dollars
- 2024 to 2028
- ReportLinker Research
Forecast: Beta Blocking Medicine Sales in New Zealand
- Million US Dollars
- 2024 to 2028
- ReportLinker Research
Forecast: Antihypertensive Medicine Sales in New Zealand
- US Dollars Per Capita
- 2024 to 2028
- ReportLinker Research
Forecast: Antihypertensive Medicine Sales in New Zealand
- Million US Dollars
- 2024 to 2028
- ReportLinker Research
Forecast: Cardiovascular System Medicine Sales in New Zealand
- Million US Dollars
- 2024 to 2028
- ReportLinker Research
Forecast: Calcium Channel Blocking Medicine Sales in New Zealand
- Million US Dollars PPP
- 2024 to 2028
- ReportLinker Research